Martin Dreyling Selected Research

Antibodies

7/2021	COVID-19 in Patients Receiving CD20-depleting Immunochemotherapy for B-cell Lymphoma.
2/2015	Differential regulation patterns of the anti-CD20 antibodies obinutuzumab and rituximab in mantle cell lymphoma.
11/2009	Optimal application of antibodies in the treatment of follicular lymphoma: current standards and future strategies.
7/2005	Transplantation strategies for patients with follicular lymphoma.
1/2005	[Monoclonal antibody therapy for malignant lymphoma].
6/2003	Mantle cell lymphoma: therapeutic strategies are different from CLL.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Martin Dreyling Research Topics

Disease

96	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 05/2024 - 01/2003
63	Lymphoma (Lymphomas) 03/2024 - 01/2003
45	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 01/2024 - 01/2003
30	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2024 - 01/2003
26	Neoplasms (Cancer) 11/2022 - 01/2005
22	B-Cell Lymphoma (Lymphoma, B Cell) 10/2023 - 04/2006
19	Disease Progression 01/2023 - 06/2003
13	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2022 - 04/2006
13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2020 - 09/2004
11	Genetic Translocation (Chromosomal Translocation) 01/2017 - 01/2009
8	Infections 05/2024 - 02/2009
5	Residual Neoplasm 11/2023 - 03/2006
4	Neutropenia 12/2021 - 03/2014
4	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 07/2003
3	Cytokine Release Syndrome 04/2023 - 06/2015
3	Hyperglycemia 11/2021 - 01/2019
3	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2021 - 09/2010
3	Diarrhea 01/2019 - 03/2014
3	Hodgkin Disease (Hodgkin's Disease) 01/2016 - 04/2006
2	COVID-19 02/2023 - 07/2021
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 02/2023 - 10/2008
2	Thrombocytopenia (Thrombopenia) 02/2023 - 04/2010
2	Hematologic Neoplasms (Hematological Malignancy) 01/2023 - 12/2004
2	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022 - 09/2010
2	Inflammation (Inflammations) 12/2021 - 10/2018
2	Hypertension (High Blood Pressure) 11/2021 - 01/2019
2	Hemorrhage 01/2019 - 08/2015
2	Pneumonia (Pneumonitis) 01/2019 - 03/2014
2	Multiple Myeloma 01/2016 - 02/2010
2	Chromosome Aberrations (Chromosome Abnormalities) 03/2012 - 02/2009
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2011 - 12/2007
2	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 09/2010 - 03/2010

Drug/Important Bio-Agent (IBA)

54	Rituximab (Mabthera)FDA Link 04/2024 - 01/2003
21	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2023 - 01/2003
19	Bendamustine Hydrochloride FDA Link 12/2022 - 07/2007
17	ibrutinibIBA 05/2024 - 08/2013
16	Vincristine (Oncovin)FDA LinkGeneric 01/2023 - 12/2004
16	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023 - 12/2004
14	Cyclin D1IBA 01/2017 - 10/2008
12	Cytarabine (Cytosar-U)FDA LinkGeneric 04/2024 - 05/2009
12	Agammaglobulinaemia Tyrosine KinaseIBA 10/2023 - 08/2013
12	Prednisone (Sone)FDA LinkGeneric 01/2023 - 12/2004
12	Monoclonal AntibodiesIBA 01/2021 - 11/2004
10	Bortezomib (Velcade)FDA Link 04/2024 - 06/2003
9	Proteins (Proteins, Gene)FDA Link 10/2021 - 11/2006
8	tisagenlecleucelIBA 01/2024 - 12/2021
8	temsirolimus FDA Link 12/2023 - 06/2013
8	Biomarkers (Surrogate Marker)IBA 12/2021 - 08/2007
8	fludarabineIBA 01/2021 - 01/2003
7	Chimeric Antigen ReceptorsIBA 04/2023 - 11/2019
7	Lenalidomide (CC 5013)FDA Link 01/2021 - 09/2008
6	AntibodiesIBA 07/2021 - 06/2003
5	Dexamethasone (Maxidex)FDA LinkGeneric 04/2024 - 08/2016
5	Proteasome InhibitorsIBA 10/2023 - 09/2008
5	copanlisibIBA 11/2021 - 12/2017
5	AntigensIBA 05/2021 - 01/2007
5	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2007 - 01/2003
4	obinutuzumabIBA 07/2023 - 02/2015
4	DNA (Deoxyribonucleic Acid)IBA 09/2015 - 09/2009
3	Cisplatin (Platino)FDA LinkGeneric 01/2023 - 08/2016
3	Prednisolone (Predate)FDA LinkGeneric 12/2022 - 06/2014
3	Complement System Proteins (Complement)IBA 11/2022 - 01/2005
3	axicabtagene ciloleucelIBA 07/2022 - 01/2021
3	CytokinesIBA 12/2021 - 10/2018
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2021 - 12/2017
3	Interferon-alpha (Interferon Alfa)IBA 09/2021 - 11/2004
3	purineIBA 01/2021 - 09/2004
3	tafasitamabIBA 01/2021 - 01/2020
3	idelalisibIBA 04/2016 - 03/2014
3	Alkylating AgentsIBA 01/2015 - 02/2010
2	venetoclaxIBA 04/2024 - 01/2018
2	Gemcitabine FDA Link 03/2024 - 01/2022
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2024 - 01/2022
2	brexucabtagene autoleucelIBA 11/2023 - 10/2023
2	VaccinesIBA 02/2023 - 10/2008
2	TOR Serine-Threonine KinasesIBA 11/2021 - 09/2008
2	AutoantigensIBA 10/2021 - 10/2008
2	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 07/2021 - 01/2021
2	Etoposide (VP 16)FDA LinkGeneric 04/2021 - 01/2021
2	LigandsIBA 10/2019 - 01/2015
2	Protein Isoforms (Isoforms)IBA 01/2019 - 12/2017
2	B-Cell Antigen Receptors (B Cell Antigen Receptors)IBA 10/2017 - 01/2016
2	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2014 - 03/2009
2	enzastaurinIBA 07/2014 - 02/2010
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 05/2014 - 11/2009
2	Chlorambucil (Leukeran)FDA Link 03/2011 - 09/2006

Therapy/Procedure

78	Therapeutics 04/2024 - 06/2003
38	Drug Therapy (Chemotherapy) 03/2024 - 01/2003
23	Stem Cell Transplantation 05/2024 - 11/2004
8	Salvage Therapy 01/2020 - 04/2006
6	Transplantation 10/2023 - 07/2005
6	Chemoradiotherapy 01/2023 - 11/2004
6	Radiotherapy 07/2022 - 05/2013
4	Precision Medicine 11/2022 - 06/2015
4	Radioimmunotherapy 12/2011 - 07/2005
3	Cell Transplantation 12/2021 - 05/2019
2	Hematopoietic Stem Cell Transplantation 10/2023 - 07/2013
2	Induction Chemotherapy 01/2022 - 01/2019
2	Time-to-Treatment 01/2018 - 03/2005
2	Homologous Transplantation 03/2015 - 07/2005